Analysis of the mutational landscape of 19/40 tumors in the novel group using targeted next-generation sequencing revealed TERT promoter mutations (C228T) in two of the cases (Supplementary Table 1, online resource), with no other relevant events involving putative brain tumor genes. Here, TERT is linked to brain neoplasm.